Abstract
Raman spectroscopy which is based upon inelastic scattering of photons has a potential to emerge as a noninvasive bedside in vivo or ex vivo molecular diagnostic tool. There is a need to improve the sensitivity and predictability of Raman spectroscopy. We developed a grid matrix-based tissue mapping protocol to acquire cellular-specific spectra that also involved digital microscopy for localizing malignant and lymphocytic cells in sentinel lymph node biopsy sample. Biosignals acquired from specific cellular milieu were subjected to an advanced supervised analytical method, i.e., cross-correlation and peak-to-peak ratio in addition to PCA and PC-LDA. We observed decreased spectral intensity as well as shift in the spectral peaks of amides and lipid bands in the completely metastatic (cancer cells) lymph nodes with high cellular density. Spectral library of normal lymphocytes and metastatic cancer cells created using the cellular specific mapping technique can be utilized to create an automated smart diagnostic tool for bench side screening of sampled lymph nodes. Spectral library of normal lymphocytes and metastatic cancer cells created using the cellular specific mapping technique can be utilized to develop an automated smart diagnostic tool for bench side screening of sampled lymph nodes supported by ongoing global research in developing better technology and signal and big data processing algorithms.
Similar content being viewed by others
References
American Cancer Society (2015) Global cancer facts & figures, 3rd edn. American Cancer Society, Atlanta
IARC-WHO (2008) World cancer report 2008 in. Boyle P, Levin B Eds. International Agency for Research on Cancer and World Health Organization
Khokhar A (2012) Breast cancer in India: where do we stand and where do we go? Asian Pac J Cancer Prev 10:4861–4866
Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663
A. D. A. M. Medical encyclopedia (2012) Lymph node biopsy
Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98:599–609
Fleissig A, LJ F, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomized trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 3:279–293
Gill G, SNAC Trial Group of the Royal Australasian College of Surgeons (RACS), NHMRC Clinical Trials Centre (2009) Sentinel-lymph-node-based management or routine axillary clearance? one-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16:266–275. doi:10.1245/s10434-008-0229-z
Raman CV, Krishnan KS (1928) A new type of secondary radiation. Nature 121(3048):501–502
Pappas D, Smith BW, Winefordner JD et al (2000) Raman spectroscopy in bioanalysis. Talanta 51:131–144
Cheng G, Kurita S, Torigian DA, Alavi A (2011) Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging 38(3):562–575. doi:10.1007/s00259-010-1577-z
García-Flores AF, Raniero L, Canevari RA, Jalkanen KJ, Bitar RA, Martinho HS, Martin AA (2011) High-wavenumber FT-Raman spectroscopy for in vivo and ex vivo measurements of breast cancer. Theor Chem Acc 130:1231–1238
Soares JS, Barman I, Dingari NC, Volynskaya Z, Liu W, Klein N, Plecha D, Dasari RR, Fitzmaurice M (2012) Diagnostic power of diffuse reflectance spectroscopy for targeted detection of breast lesions with microcalcifications. Proc Natl Acad Sci U S A 110(2):471–476. doi:10.1073/pnas.1215473110
Utzinger U, Heintzelman DL, Mahadevan-Jansen A, Malpica A, Follen M, Richards-Kortum R (2001) Near-infrared Raman spectroscopy for in vivo detection of cervical precancers. Appl Spectrosc 55:955–959
Bhushan B, Pradhan A (2013) A detection of breast & cervical cancer using Raman spectroscopy. Intl J Innov Res Sci Eng Technol 2:3420–3425
Bitar Carter RA, Martin AA, Netto MM, Soares FA (2004) FT-Raman spectroscopy study of human breast tissue. SPIE Proc 5321:190–197
Olds WJ, Jaatinen E, Fredericks P, Cletus B, Panayiotou H, Izake EL (2011) Spatially offset Raman spectroscopy (SORS) for the analysis and detection of packaged pharmaceuticals and concealed drugs. Forensic Sci Int 212(1–3):69–77
Macleod NA, Matousek P (2007/2008) Enhancement of signal in transmission Raman spectroscopy of turbid media, Lasers for science facility (lsf) programme, Central laser facility annual report 200–202
De Jong BWD, Bakker Schut TC, Maquelin K, van der Kwast T, Bangma CH, Kok D-J, Puppels GJ (2006) Discrimination between Non-tumor bladder tissue and tumor by Raman spectroscopy. Anal Chem 78(22):7761–7769
Crane NJ, Brown TS, Evans KN, Hawksworth JS, Hussey S, Doug K, Tadaki DK, Eric A, Elster EA (2010) Monitoring the healing of combat wounds using Raman spectroscopic mapping. Wound Repair Regen 18(4):409–416
Powdrill S (2009) Beyond the red reflex: examining the eye with an ophthalmoscope. JAAPA 22(10):2534–2538, CME posttest http://connection.ebscohost.com/c/articles/44529984/beyond-red-reflex-examining-eye-ophthalmoscope
The merck manual-home health handbook, patients & caregivers, eye disorders, diagnosis of eye disorders, The eye examination; source: http://www.merckmanuals.com/home/eye_disorders/diagnosis_of_eye_disorders/the_eye_examination.html
Baecker V (2008) MRI Grid – Mri- CNRS mri-cia-source. zip: http://www.mri.cnrs.fr/index.php?m=62&c=72
Ali SM, Bonnier F, Tfayli A, Lambkin H, Flynn K, McDonagh V, Healy C, Clive Lee T, Lyng FM, Byrne HJ (2013) Raman spectroscopic analysis of human skin tissue sections ex-vivo: evaluation of the effects of tissue processing and dewaxing. J Biomed Opt 6:061202. doi:10.1117/1.JBO.18.6.061202
Shetty G, Kendall C, Shepherd N, Stone N, Barr H (2006) Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus. Br J Cancer 94(10):1460–1464. doi:10.1038/sj.bjc.6603102
Crow P, Barrass B, Kendall C, Hart-Prieto M, Wright M, Persad R, Stone N (2005) The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines. Br J Cancer 92:2166–2170. doi:10.1038/sj.bjc.6602638
Singh SP, Deshmukh A, Chaturvedi P, Murali Krishna C (2012) In vivo Raman spectroscopic identification of premalignant lesions in oral buccal mucosa. J Biomed Opt 17(10):105002. doi:10.1117/1.JBO.17.10.105002
Chowdary MV, Kumar KK, Kurien J, Mathew S, Krishna CM (2006) Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy. Biopolymers 83(5):556–569
Malini R, Venkatakrishna K, Kurien J, Pai KM, Rao L, Kartha VB, Krishna CM (2006) Discrimination of normal, inflammatory, premalignant, and malignant oral tissue: a Raman spectroscopy study. Biopolymers 81(3):179–193
Kalyan Kumar K, Chowdary MVP, Stanley M, Lakshmi R, Murali Krishna C, Jacob K (2008) Raman spectroscopic diagnosis of breast cancers: evaluation of models. J Raman Spectrosc. doi:10.1002/jrs.1991
Keating ME, Bonnier F, Byrne H (2012) Spectral cross correlation as a supervised approach for the analysis of complex Raman datasets: the case of nanoparticles in biological cells. Analyst 137(24):5792–5802
Mo J, Zheng W, Low J, Ng JS, Ilancheran A, Huang Z (2009) High wave number Raman spectroscopy for in vivo detection of cervical dysplasia. Anal Chem 81:8908–8915
Nijssen A, Maquelin K, Santos LF, Caspers PJ, Bakker Schut TC, den Hollander JC, Neumann MH, Puppels GJ (2007) Discriminating basal cell carcinoma from perilesional skin using high wave-number Raman spectroscopy. J Biomed Opt 12(3):034004
Koljenović S, Bakker Schut TC, Wolthuis R, de Jong B, Santos L, Caspers PJ, Kros JM, Puppels GJ (2005) Tissue characterization using high wave number Raman spectroscopy. J Biomed Opt 10(3):031116
Chau, Alexandra H (2009) Development of an intracoronary Raman spectroscopy. Theses, Massachusetts institute of technology
Haka AS, Shafer-Peltier KE, Fitzmaurice M, Crowe J, Dasari RR, Feld MS (2005) Diagnosing breast cancer by using Raman spectroscopy. PNAS 102:12371–12376
Movasaghi Z, Rehman S, Rehman IU (2007) Raman spectroscopy of biological tissues. Appl Spectrosc Rev 42:493–541
Gelder JD, Gussem KD, Vandenabeele P, Moens L (2007) Reference database of Raman spectra of biological molecules. J Raman Spectrosc 38:1133–1147
Mahadevan-Jansen A, Richards-Kortum R (1997) Raman spectroscopy for cancer detection: a review. Proceedings- 19th International conference, IEEE/EMBS 2722–28
Isabelle M, Stone N, Barr H, Vipond M, Shepherd N, Rogers K (2008) Lymph node pathology using optical spectroscopy in cancer diagnostics. Spectroscopy 22(2–3):97–104
Keshtgar MR, Chicken DW, Austwick MR, Somasundaram SK, Mosse CA, Zhu Y, Bigio IJ, Bown SG (2010) Optical scanning for rapid intraoperative diagnosis of sentinel node metastases in breast cancer. Br J Surg 97:1232–1239. doi:10.1002/bjs.7095
Chan JW, Taylor DS, Zwerdling T, Lane SM, Ihara K, Huser T (2006) Micro-Raman spectroscopy detects individual neoplastic and normal hematopoietic cells. Biophys J 90(2):648–656. doi:10.1529/biophysj.105.066761
Krishna CM, Sockalingum GD, Kegelaer G, Rubin S, Kartha VB, Manfait M (2005) Micro-Raman spectroscopy of mixed cancer cell populations. Vib Spectrosc 38:95–100. doi:10.1016/j.vibspec.2005.02.018
Acknowledgments
We are grateful to Dr. Surya Pratap Singh, Rubina Shaikh, Aditi Sahu, Piyush Kumar, and Tanmoy Bannerjee (Chilakapati lab) for assisting in PCA and LDA analysis, Jayraj and Tanuja for digital imaging, and Dr. Amin and Mr. Madan for tumor tissue repository service. Special thanks also to the intern of the lab, Jugal Bhojak for helping in the grid matrix illustrations.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
There is no conflict of interest.
Appendix 1
Appendix 1
PCA/PC-LDA: PCA (principal component analysis) is a known data reduction technique where huge spectral data are decomposed into small independent variables known as “factors,” and contributions of these factors are called “scores”. In short, PCA involves a mathematical procedure that transforms a number of (possibly) correlated variables into a (smaller) number of uncorrelated variables called principal components. The first principal component accounts for as much of the variability in the data as possible, and each succeeding component accounts for as much of the remaining variability (lesser than the preceding principal component) as possible. Spectral data analysis is carried out over entire region and on the high frequency region following with plotting of factor 1 versus 2 in this technique.
Correlation and peak-to-peak ratio (PPR) analysis—Raman spectra signals
To analyze unknown/unbiased Raman spectra signals, basic concept of correlation rather than the complex signal discrimination techniques is used here. Correlation is a measure of the similarity between two signals, and when both the signals are same, it is called autocorrelation. In signal processing, cross-correlation is a measure of similarity of two waveforms as a function of a time-lag applied to one of them. It is commonly used for searching a long signal for a shorter, known feature. It also has applications in pattern recognition, single particle analysis, electron tomographic averaging, cryptanalysis, and neurophysiology.
Data Observation: Correlation—Any correlation coefficient value >0.9995 is considered to be considerably high, and the signals have high similarity. Any correlation coefficient value <0.9960 ± 0.0005 is considered to be quite different, and the signals have distinct features. Even though this may be minute difference for general signals, it is quite high variation for biomedical signals, which is also seen from the peak ratios. De-noised signals (using MATLAB command, cmd denoise) for all tissues were also analyzed for correlation coefficient value, and it gives 99% or more of the same correlation value, and in few cases, it gives a little higher (+0.0001) correlation coefficient value. It never gives lesser correlation (as compared to the noisy original signal) as the signal is de-noised with some minute peaks which may be important medically, flattened out.
Peak ratio—Peak ratio is taken on de-noised signals as the “ratio” will not change much even if we average out the signal. The intensity value changes by de-noising, but it changes almost equally at all points. The wave number range (cm−1 as generated from the Raman spectra measurement device) from which specific peaks (the highest intensity peak in these range is chosen to take the ratio) are chosen is – Peak1 −804.029 to 911.677; Peak2 −922.363 to 1028.45; Peak3 −1233.01 to 1334.98; Peak4 −1398.86 to 1498.62; Peak5 −1606.83 to 1703.83; Peak6 −2814.44 to 2895.14. This is based on human observation of signals that major peaks occur at those particular locations consistently in all signals, with varying intensities. We observed same results with peak ratio analysis as obtained by cross-correlation.
Appendix
Correlation value for all tissues :-
In MATLAB (.mat) files
Peak ratio code for tissue 30 :- (Similar for all other tissues)
Rights and permissions
About this article
Cite this article
Som, D., Tak, M., Setia, M. et al. A grid matrix-based Raman spectroscopic method to characterize different cell milieu in biopsied axillary sentinel lymph nodes of breast cancer patients. Lasers Med Sci 31, 95–111 (2016). https://doi.org/10.1007/s10103-015-1830-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-015-1830-6